Streetbeat News

Stock Prices

ACMR

ACM Research (NASDAQ:ACMR) has significantly outperformed the market over the past 5 years, delivering an average annual return of 26.07%. A $100 investment in ACMR 5 years ago would be worth $327.64 today. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 4:00 pm

PNTG

Pennant Group Inc (NASDAQ:PNTG) has been analyzed by 4 analysts over the past three months, showing a range of perspectives from bullish to bearish. The average 12-month price target is $28.0, with a high of $34.00 and a low of $25.00. Recent analyst actions include rating upgrades and price target increases, reflecting positive sentiment. The company has shown strong financial performance with significant revenue growth, high net margins, and strong ROE and ROA, but faces challenges with a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 4:00 pm

PANW

Palo Alto Networks (NASDAQ:PANW) has significantly outperformed the market over the past 10 years, delivering an average annual return of 27.23%. A $100 investment in PANW 10 years ago would be worth $1,159.30 today. The company's current market capitalization is $101.68 billion.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 4:00 pm

UMH

UMH Properties (NYSE:UMH) has been analyzed by 4 analysts, revealing mixed sentiments. The average 12-month price target is $19.12, up 9.26% from the previous $17.50. Analysts' ratings range from 'Neutral' to 'Buy', with price targets between $17.00 and $21.00. UMH Properties has shown strong revenue growth but faces challenges with profitability, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 4:00 pm

DVAX

Dynavax Technologies (NASDAQ:DVAX) has been analyzed by 4 analysts over the past three months, showing a range of perspectives from bullish to bearish. The average 12-month price target is $25.5, down 4.67% from the previous $26.75. Key analysts include Paul Choi from Goldman Sachs, who lowered his target to $15.00, and Edward White from HC Wainwright & Co., who maintained a $29.00 target. Dynavax has shown positive revenue growth and strong financial performance, but its debt-to-equity ratio is higher than the industry average.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 4:00 pm

DIS

Analysts have mixed views on The Walt Disney Company's (NYSE:DIS) recent performance, with concerns about theme park weakness offset by strong streaming profits. Multiple analysts have reiterated Buy ratings but lowered their price targets. The focus is on the normalization of theme park profitability and the strength of Disney's Direct-to-Consumer (DTC) segment.

Portfolio Pulse from Chris Katje

August 08, 2024 | 3:58 pm

CRLBF

Cresco Labs Inc. reported its Q2 2024 financial results, showing a 9% YoY increase in gross profit but a nearly 7% drop in revenue. The company achieved $184.3 million in net revenues and $94.8 million in gross profit. Despite a net loss of $51.2 million, Cresco's shares rose 2.80% to $1.48 per share.

Portfolio Pulse from Jelena Martinovic

August 08, 2024 | 3:56 pm

MGRM

Monogram Technologies shares are trading higher after the company announced that it has submitted a premarket filing to the FDA for its mBôs TKA System.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 3:51 pm

MRK

RHHBY

Merck & Co Inc (NYSE:MRK) has discontinued its Phase 3 KeyVibe-008 trial for a Keytruda combination due to ineffective results and higher adverse events. The trial compared the combination to Roche's Tecentriq for treating extensive-stage small cell lung cancer. Merck is notifying investigators and offering alternative treatments. The stock is up 0.82% following the announcement.

Portfolio Pulse from Vandana Singh

August 08, 2024 | 3:51 pm

EME

EMCOR Group's (NYSE:EME) short interest has fallen by 16.36%, with 666 thousand shares sold short, representing 1.84% of its float. This is lower than the peer group average of 5.86%. The decrease in short interest may indicate a more bullish sentiment among investors.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 3:45 pm